Haemonetics Corporation (HAE) EBITDA margin US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 17.1% | 21.3% | 21.3% | 23.3% | 19.6% | |||
Changes by years, y/y, % | +1pp | +4pp | 0pp | -21pp | +3.2% |
Haemonetics Corporation. EBITDA margin, %
Haemonetics Corporation. EBITDA margin, changes, pp
Haemonetics Corporation (HAE) EBITDA margin US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
EBITDA margin, % | ? | 24.6% | 16.6% | 20.7% | 18.0% | 23.0% | 19.6% | |
Changes by years, y/y, % | +4pp | -7pp | -1pp | -1pp | +4pp | |||
Changes by quarters, q/q, % | +5pp | -8pp | +4pp | -3pp | +5pp |